![Andrew Yuen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Yuen
Analyst-Equity at Gordonmd Global Investments LP
Profile
Mr. Andrew Yuen is a Senior Analyst at Gordonmd Global Investments LP.
Prior to joining, He was an Equity Research Associate for two years at The Capital Group.
Before joining The Capital Group, He was employed by J.P.
Morgan Securities LLC.
He holds a bachelor’s degree in Business Administration, with a concentration in Finance, from the University of Washington.
Andrew Yuen active positions
Companies | Position | Start |
---|---|---|
Gordonmd Global Investments LP
![]() Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Analyst-Equity | 31/12/2020 |
Training of Andrew Yuen
University of Washington | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Gordonmd Global Investments LP
![]() Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Finance |
- Stock Market
- Insiders
- Andrew Yuen